Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhật$310,083 KL.
Mar 31, 2026
June 30
13%
December 31
38%
$310,083 KL.
June 30
$19,514 KL.
13%
December 31
$25,686 KL.
38%
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Thị trường mở: Feb 7, 2026, 5:04 PM ET
Khối lượng
$310,083Ngày kết thúc
Mar 31, 2026Thị trường mở
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Khối lượng
$310,083Ngày kết thúc
Mar 31, 2026Thị trường mở
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhật
Cẩn thận với liên kết bên ngoài.
Cẩn thận với liên kết bên ngoài.
Câu hỏi thường gặp